New therapeutic targets in cancer: the epigenetic connection

Michel Herranz1, Manel Esteller

  • 1Cancer Epigenetics Laboratory, Molecular Pathology Program, Spanish National Cancer Centre (CNIO), Madrid, Spain.

Insights

Cancer is an epigenetic disease driven by DNA modifications and chromatin changes. Reversing these epigenetic alterations offers a promising new therapeutic strategy for cancer treatment and diagnosis.

Area of Science:

  • Oncology
  • Epigenetics
  • Molecular Biology

Background:

  • Cancer is fundamentally an epigenetic disease.
  • Epigenetic dysregulation involves DNA methylation, histone modifications, and chromatin remodeling.
  • These alterations impact gene expression, promoting cancer development.

Purpose of the Study:

  • To highlight the role of epigenetic modifications in cancer.
  • To explore the therapeutic potential of reversing epigenetic changes.
  • To emphasize the future diagnostic and prognostic value of epigenetic markers.

Main Methods:

  • Analysis of DNA methylation patterns.
  • Assessment of histone acetylation and methylation.
  • Chromatin remodeling studies.

Main Results:

  • Aberrant DNA methylation, particularly promoter hypermethylation, represses cancer-associated genes.
  • Histone deacetylation and methylation also contribute to transcriptional repression.
  • Reversing these epigenetic marks can restore the expression of tumor-suppressor genes.

Conclusions:

  • Epigenetic modifications are key drivers of cancer.
  • Targeting epigenetic processes represents a novel therapeutic avenue.
  • Epigenetic patterns hold significant potential for cancer diagnosis, prognosis, and personalized therapy.

Related Concept Videos

Epigenetic Regulation01:37

Epigenetic Regulation

Epigenetic changes alter the physical structure of the DNA without changing the genetic sequence and often regulate whether genes are turned on or off. This regulation ensures that each cell produces only proteins necessary for its function. For example, proteins that promote bone growth are not produced in muscle cells. Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
X-chromosome...
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Epigenetic Regulation01:46

Epigenetic Regulation

Epigenetic mechanisms play an essential role in healthy development. Conversely, precisely regulated epigenetic mechanisms are disrupted in diseases like cancer.
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...